4D Molecular Therapeutics, Inc. earnings per share and revenue

FDMT earnings per share for the last quarter are -0.89 USD whereas the estimation was -0.84 USD which accounts for -6.53% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 1.42 M USD. Estimated earnings per share for the next quarter are -0.86 USD, and revenue is expected to reach 529.67 k USD. Also watch annual changes over time to get a bigger picture of FDMT earnings per share and revenue dynamics.